Article Text

Download PDFPDF
Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors HF and PE equally contributed to the planning, conduct and reporting of the case and corresponding literature search for the work described in the Letter to the Editor, ‘Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma’. HF is responsible for the overall content as a guarantor.

  • Competing interests None.

  • Ethics approval This Letter to the Editor submission was discussed with the Barwon Health Research Department who felt that no Ethics Committee/Institutional Review Board approval was necessary. They felt that the patient has been deidentified in such a way that no individual could identify the patient with any degree of certainty.

  • Provenance and peer review Not commissioned; internally peer reviewed.